Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Bennett

Showing results (131-140 of 371) with videos related to

Pageof 38
Sort By:
Drugs|January 29, 2000
A practical guide to the management of hypertension in renal transplant recipientsA J Olyaei, A M deMattos, W M Bennett
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Selective suppression of rat hepatic microsomal activity during chronic cyclosporine nephrotoxicityL J Brunner, W M Bennett, D R Koop
Current Opinion in Nephrology and Hypertension|September 16, 2000
Renal toxicity of protease inhibitorsA J Olyaei, A M deMattos, W M Bennett
Drug Safety|June 1, 1997
Switching between cyclosporin formulations. What are the risks?A J Olyaei, A M deMattos, W M Bennett
The New England Journal of Medicine|November 22, 1979
Acute renal failure from ticrynafenW M Bennett, P E Van Zee, R Hutchings
Annals of Internal Medicine|March 1, 1981
Aspirin-induced depression of glomerular filtration rate in normal humans: role of sodium balanceR S Muther, D M Potter, W M Bennett
Clinical Pharmacology and Therapeutics|June 1, 1975
Morphine and phenytoin binding to plasma proteins in renal and hepatic failureG D Olsen, W M Bennett, G A Porter
Renal Failure|July 23, 1999
An animal model of chronic cyclosporine nephrotoxicityG A Porter, T F Andoh, W M Bennett
Proceedings (Baylor University. Medical Center)|January 4, 2006
Chinese herb nephropathyM M Meyer, T P Chen, W M Bennett
Journal of Clinical Pharmacology|October 1, 1983
Unraveling aminoglycoside nephrotoxicity using animal modelsG A Porter, W M Bennett, D N Gilbert
Pageof 38

Showing results (131-140 of 371) with videos related to

Sort By:
Pageof 38
Drugs|January 29, 2000
A practical guide to the management of hypertension in renal transplant recipientsA J Olyaei, A M deMattos, W M Bennett
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Selective suppression of rat hepatic microsomal activity during chronic cyclosporine nephrotoxicityL J Brunner, W M Bennett, D R Koop
Current Opinion in Nephrology and Hypertension|September 16, 2000
Renal toxicity of protease inhibitorsA J Olyaei, A M deMattos, W M Bennett
Drug Safety|June 1, 1997
Switching between cyclosporin formulations. What are the risks?A J Olyaei, A M deMattos, W M Bennett
The New England Journal of Medicine|November 22, 1979
Acute renal failure from ticrynafenW M Bennett, P E Van Zee, R Hutchings
Annals of Internal Medicine|March 1, 1981
Aspirin-induced depression of glomerular filtration rate in normal humans: role of sodium balanceR S Muther, D M Potter, W M Bennett
Clinical Pharmacology and Therapeutics|June 1, 1975
Morphine and phenytoin binding to plasma proteins in renal and hepatic failureG D Olsen, W M Bennett, G A Porter
Renal Failure|July 23, 1999
An animal model of chronic cyclosporine nephrotoxicityG A Porter, T F Andoh, W M Bennett
Proceedings (Baylor University. Medical Center)|January 4, 2006
Chinese herb nephropathyM M Meyer, T P Chen, W M Bennett
Journal of Clinical Pharmacology|October 1, 1983
Unraveling aminoglycoside nephrotoxicity using animal modelsG A Porter, W M Bennett, D N Gilbert
Pageof 38